T&R Biofab Co., Ltd Logo

T&R Biofab Co., Ltd

Develops 3D bioprinted scaffolds for tissue repair in orthopedics, surgery, and dentistry.

246710 | KO

Overview

Corporate Details

ISIN(s):
KR7246710008
LEI:
Country:
South Korea
Address:
경기도 시흥시 마유로 96, 시흥시
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

T&R Biofab Co., Ltd. is a biomedical engineering company specializing in regenerative medicine and tissue engineering. Leveraging its proprietary 3D bioprinting technology, the company develops and commercializes products designed for tissue and organ regeneration and reconstruction. Its core offerings include 3D-printed bioresorbable scaffolds, bio-inks, bio-surgical solutions, organoids, and induced pluripotent stem cells (hiPSC). These advanced solutions cater to various medical fields, including orthopedics, plastic surgery, and dentistry, aiming to provide innovative treatments for tissue repair and transplantation.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-09-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-09-16 00:00
Registration Form
[기재정정]증권신고서(지분증권) (2025.10)
Korean 3.9 MB
2025-09-16 00:00
Prospectus
[기재정정]투자설명서
Korean 3.8 MB
2025-09-15 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-09-12 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 97.7 KB
2025-09-09 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 96.0 KB
2025-09-08 00:00
Share Issue/Capital Change
유상증자1차발행가액결정
Korean 8.0 KB
2025-09-08 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(유무상증자결정)
Korean 54.6 KB
2025-09-08 00:00
Share Issue/Capital Change
[발행조건확정]증권신고서(지분증권)
Korean 568.9 KB
2025-09-08 00:00
Prospectus
투자설명서
Korean 3.7 MB
2025-09-08 00:00
Share Issue/Capital Change
권리락 (유상증자)
Korean 3.5 KB
2025-09-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 123.1 KB
2025-08-22 00:00
Registration Form
[기재정정]증권신고서(지분증권) (2025.10)
Korean 4.9 MB
2025-08-21 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.9 MB

Automate Your Workflow. Get a real-time feed of all T&R Biofab Co., Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for T&R Biofab Co., Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for T&R Biofab Co., Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

3-D Matrix,Ltd. Logo
Develops peptide-based medical devices for surgical bleeding control and wound healing.
Japan
7777
aap Implantate AG Logo
Develops and markets orthopedic trauma implants and plating systems for fracture treatment globally.
Germany
AAQ1
ABL Diagnostics Logo
Develops integrated diagnostic solutions for infectious diseases for labs, clinicians, & researchers.
France
ABLD
Adagio Medical Holdings, Inc. Logo
Develops ultra-low temp cryoablation catheters for cardiac arrhythmia treatment.
United States of America
ADGM
Advanced Biomed Inc. Logo
Develops microfluidic biochips for rapid, affordable liquid biopsy in precision oncology.
United States of America
ADVB
ADVANCED MEDICAL SOLUTIONS GROUP PLC Logo
Develops and manufactures innovative tissue-healing technologies for wound care and surgery.
United Kingdom
AMS
AETHLON MEDICAL INC Logo
Develops a blood-filtering device to combat resistant cancers and life-threatening viruses.
United States of America
AEMD
Affluent Medical Logo
Developing minimally invasive, restorative implants for structural heart disease and urology.
France
AFME
Ainos, Inc. Logo
Develops AI-powered 'SmellTech' diagnostics and immune therapies for point-of-care testing.
United States of America
AIMD
AIOBIO Co., Ltd. Logo
Develops AI biofluorescence dental tools for early detection of caries and plaque.
South Korea
447690

Talk to a Data Expert

Have a question? We'll get back to you promptly.